Cite
HARVARD Citation
Mace, T. et al. (2015). Anti-IL-6 and PD-L1 antibody combination therapy reduces tumor progression in murine models of pancreatic cancer. Journal for immunotherapy of cancer. 3 (2), pp. 1-2. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Mace, T. et al. (2015). Anti-IL-6 and PD-L1 antibody combination therapy reduces tumor progression in murine models of pancreatic cancer. Journal for immunotherapy of cancer. 3 (2), pp. 1-2. [Online].